38
Views
4
CrossRef citations to date
0
Altmetric
Original

Role of the molecular staging and response in the management of follicular lymphoma patients

, , , , , , , , , , , , & show all
Pages 1018-1022 | Received 14 Mar 2005, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bridgette Collins-Burow & Edgardo S Santos. (2007) Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma. Expert Review of Anticancer Therapy 7:3, pages 257-273.
Read now

Articles from other publishers (3)

Laura Magnano, Silvia Montoto, Eva González-Barca, Javier Briones, Juan Manuel Sancho, Ana Muntañola, Antonio Salar, Joan Besalduch, Lourdes Escoda, Carol Moreno, Eva Domingo-Domenech, Cristina Estany, Albert Oriol, Albert Altés, Carmen Pedro, Santiago Gardella, Antoni Asensio, Pilar Vivancos, Alberto Fernández de Sevilla, Josep María Ribera, Dolors Colomer, Elias Campo & Armando López-Guillermo. (2017) Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial. Annals of Hematology 96:4, pages 639-646.
Crossref
Faramarz Naeim, P. Nagesh Rao & Wayne W. Grody. 2008. Hematopathology. Hematopathology 297 372 .
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:1, pages 44-51.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.